Status:
COMPLETED
Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
University of Western Ontario, Canada
University of Calgary
Conditions:
Ulcerative Colitis
Inflammatory Bowel Disease
Eligibility:
All Genders
18-85 years
Brief Summary
In this cross-sectional study patients with active or quiescent ulcerative colitis will be studied to determine the utility of endoscopic ultrasound measurements of rectal wall blood flow and thicknes...
Detailed Description
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) of unknown etiology characterized by diffuse mucosal inflammation limited to the colon. The basis of medical treatment is with age...
Eligibility Criteria
Inclusion
- Patients with a confirmed diagnosis of ulcerative colitis aged 18-85
- Patients termed either "active" or "inactive" UC
- Patients may be treatment naïve (ie: new diagnosis) or on existing therapy including 5'ASA (oral or topical), AZA, corticosteroids, or IFX
Exclusion
- Inability to or unwillingness to undergo flexible sigmoidoscopy or colonoscopy
- Inability to provide informed consent
- Crohn's disease 4. Presence of an ileoanal pouch
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01852760
Start Date
September 1 2013
End Date
July 1 2015
Last Update
October 2 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Health Care
London, Ontario, Canada, N6A 4V2